|
|
Volumn 346, Issue 15, 2002, Pages 1119-1126
|
|
A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis
a,f
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GANCICLOVIR;
VALGANCICLOVIR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
DISEASE ASSOCIATION;
DISEASE COURSE;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG HYDROLYSIS;
DRUG SAFETY;
FEMALE;
HUMAN;
LONG TERM CARE;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
MALE;
NEUTROPENIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RETINA DETACHMENT;
RETINITIS;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADMINISTRATION, ORAL;
ADULT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS RETINITIS;
DISEASE PROGRESSION;
FEMALE;
GANCICLOVIR;
HIV;
HUMANS;
INJECTIONS, INTRAVENOUS;
MALE;
PRODRUGS;
VIRAL LOAD;
|
|
EID: 0037061903
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMoa011759 Document Type: Article |
|
Times cited : (344)
|
|
References (18)
|
